According to our (Global Info Research) latest study, the global Blood Hematology Units market size was valued at US$ 1388 million in 2025 and is forecast to a readjusted size of US$ 1855 million by 2032 with a CAGR of 4.2% during review period.
Blood hematology units refer to functional testing units used for automated blood sample detection, classification, identification, and data output. They can operate as standalone hematology testing devices or be integrated into laboratory automation lines, emergency testing platforms, or regional laboratory systems. Their core functions include blood cell counting, white blood cell differentiation, hemoglobin measurement, platelet analysis, abnormal cell flagging, quality control management, and result transmission. They support clinical applications such as infection assessment, anemia screening, hematological disease monitoring, preoperative evaluation, and treatment follow-up. Compared with traditional standalone devices, blood hematology units place greater emphasis on modularity, connectivity, and system collaboration. They can work with sample preprocessing, slide-making, digital review, laboratory information systems, and remote quality control platforms, making them essential foundational units for modern laboratories seeking higher efficiency, diagnostic consistency, and operational management capability.In 2025, global Blood hematology units production reached approximately 111.93 k units and price is about 12.05 k USD/Unit.The average gross profit margin of this product is 45%.
Market opportunities for blood hematology units are driven by laboratory automation upgrades, hospital efficiency improvement, regional laboratory center development, and the expansion of primary healthcare capacity. As hospital laboratories shift from single-test operations toward workflow-based, platform-based, and intelligent management, blood hematology units are no longer merely devices for routine blood testing; they are key nodes connecting sample flow, data flow, and clinical decision flow. Large hospitals require system units with higher throughput, stronger abnormality detection, and better automation line compatibility, while county hospitals and primary care institutions need stable, easy-to-maintain, and cost-controlled testing capability. Medical equipment renewal, domestic substitution, and smart hospital development further enhance the strategic value of blood hematology units. For manufacturers, companies that integrate instruments, reagents, software, quality control, and services into a complete solution are better positioned to build long-term customer relationships and recurring business returns.
The blood hematology unit market is moving from hardware performance competition to system ecosystem competition. Companies must compete not only on testing speed and parameter coverage, but also on algorithm capability, reagent stability, system compatibility, and service responsiveness. High-end customers have strict requirements for abnormal cell identification, result consistency, automatic reflex testing, data traceability, and automation line connectivity, leading to long product validation cycles and high customer switching costs. In the mid- and low-end markets, tender price pressure, channel competition, and product homogenization are increasing. Since blood hematology units typically depend on supporting reagents, calibrators, quality control materials, and maintenance services, any supply chain fluctuation, reagent batch inconsistency, or insufficient engineering response may affect user experience and brand trust. In the future, companies lacking core components, software algorithms, and service networks may be marginalized as competition intensifies.
Downstream demand is evolving toward efficiency, segmentation, and digitalization. Tertiary hospitals and large regional laboratory centers are increasingly focused on high throughput, modular expansion, automation line access, and intelligent review capability, aiming to reduce manual intervention, improve sample turnaround time, and enhance result consistency. Secondary hospitals, county hospitals, and private medical institutions place greater emphasis on device stability, testing speed, reagent supply, and total cost of ownership. Primary healthcare institutions, community health centers, and health examination centers prefer compact units with simple operation, small footprint, and low maintenance requirements. Independent medical laboratories have higher requirements for continuous operation, batch testing, and information system connectivity. Overall, purchasing logic is shifting from buying a single device to acquiring sustainable hematology testing capability, with system integration, quality control management, and service responsiveness becoming key factors in procurement decisions.
The upstream supply chain of blood hematology units mainly includes optical detection modules, fluid control components, precision mechanical structures, sensors, pumps and valves, tubing, electronic components, embedded control systems, analytical algorithms, and reagent raw materials. Among these, optical systems, fluidic systems, flow detection channels, sensors, and software algorithms directly determine testing accuracy, repeatability, stability, and abnormality flagging capability, forming the core technical barriers of the product. As domestic supply chains mature, local supporting capabilities for general structural parts, selected electronic components, and basic reagent materials continue to improve. However, high-end optical components, precision fluid control systems, highly consistent reagents, core chips, and intelligent analytical software still require strong R&D, manufacturing, and quality management capabilities. In the future, companies with stronger upstream control will be better positioned to manage costs, ensure stable delivery, accelerate product iteration, and gain greater initiative in high-end competition.
This report is a detailed and comprehensive analysis for global Blood Hematology Units market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Hematology Units market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Hematology Units market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Hematology Units market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Blood Hematology Units market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Hematology Units
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Hematology Units market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex Corporation, Danaher, Abbott Laboratories, Siemens Healthineers, HORIBA, Boule Diagnostics AB, Nihon Kohden, BioSystems, Diatron, Mindray Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Hematology Units market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Three-part Differential
Five-part Differential
Market segment by Application Scenario
Clinical
Screening
Research
Other
Market segment by System Form
Benchtop
Floor-standing
Market segment by Application
Public Hospitals
Third-party Independent Laboratory
Other
Major players covered
Sysmex Corporation
Danaher
Abbott Laboratories
Siemens Healthineers
HORIBA
Boule Diagnostics AB
Nihon Kohden
BioSystems
Diatron
Mindray Medical
DYMIND
Urit Medical
Zybio
Dirui Medical
Maccura
Sinnowa
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Hematology Units product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Hematology Units, with price, sales quantity, revenue, and global market share of Blood Hematology Units from 2021 to 2026.
Chapter 3, the Blood Hematology Units competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Hematology Units breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Blood Hematology Units market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Hematology Units.
Chapter 14 and 15, to describe Blood Hematology Units sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Blood Hematology Units. Industry analysis & Market Report on Blood Hematology Units is a syndicated market report, published as Global Blood Hematology Units Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Blood Hematology Units market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.